AIDS News and Research

RSS

UW Medicine researchers seek participants for Phase 3 clinical trial of a drug to treat monkeypox

UW Medicine researchers are recruiting participants for a Phase 3 clinical trial of a drug to treat the monkeypox virus.

16 Sep 2022

Court ruling may spur competitive health plans to bring back copays for preventive services

Tom and Mary Jo York are a health-conscious couple, going in for annual physicals and periodic colorectal cancer screening tests. Mary Jo, whose mother and aunts had breast cancer, also gets regular mammography tests.

15 Sep 2022

SARS-CoV-2 RNA and antibody detection in infected mothers’ breast milk

In a recent study published in the Journal of Medical Virology, Italian researchers investigated the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ribonucleic acid (RNA) and antibodies (Abs) in the milk of breastfeeding mothers with SARS-CoV-2 infections.

14 Sep 2022

What is the impact of COVID-19 vaccination on erectile function?

A recent study reported that COVID-19 vaccination does not elevate the risk of erectile dysfunction.

12 Sep 2022

ACTG announces the initiation of trial evaluating the safety and efficacy of monkeypox treatment

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which expanded its focus to conduct research into COVID-19, today announced the initiation of STOMP (Study of Tecovirimat for Human Monkeypox Virus), or A5418, a phase 3, randomized, placebo-controlled, double-blind trial evaluating the safety and efficacy of tecovirimat for the treatment of human monkeypox.

9 Sep 2022

Phase 3 clinical trial commences to evaluate antiviral for monkeypox

A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States.

9 Sep 2022

Potential HIV vaccine component leads to strong protection in primates

To block infection from HIV, a successful vaccine will require a combination of ingredients, including at least three antibody targets and a substance that boosts immune responses.

9 Sep 2022

COVID-19’s long-term impact on orphanhood and caregiver loss

Researchers performed epidemiologic modeling to update COVID-19-associated caregiver and parent loss estimates.

9 Sep 2022

Booster vaccination maintains high efficacy against malaria in African children

Researchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of the candidate malaria vaccine, R21/Matrix-M™ - which previously demonstrated high-level efficacy of 77% over the following 12 months in young west African children in 2021.

9 Sep 2022

Recent literature reports on the role of the gut microbiome on human health and its effect on diseases

Researchers assessed the role of the gut microbiome in human health and disease.

8 Sep 2022

Study indicates that HIV-infected and uninfected patients have similar monkeypox illness outcomes

In a recent study published in the journal HIV Medicine, German researchers evaluated the clinical characteristics of Monkeypox virus (MPXV) infections in people with and without human immunodeficiency virus (HIV) infection.

7 Sep 2022

Recent developments in the use of nanoparticles to deliver drugs to the brain via intranasal administration

Scientists have recently reviewed research articles related to the application of inorganic nanoparticles in delivering drugs to the brain through the intranasal route.

7 Sep 2022

‘It’s becoming too expensive to live’: Anxious older adults try to cope with limited budgets

Economic insecurity is upending the lives of millions of older adults as soaring housing costs and inflation diminish the value of fixed incomes.

7 Sep 2022

Dolutegravir-based regimen more effective for treating pregnant people with HIV-1

Dolutegravir-based antiretroviral therapies (ART) for HIV-1 are more effective for pregnant people than some other ART regimens commonly used in the U.S. and Europe, according to a study led by Harvard T.H. Chan School of Public Health researchers.

1 Sep 2022

The currently available evidence on viral-induced parkinsonism

A new review attempts to summarize all known about the relationship between viral illness and parkinsonian disorders to facilitate further research.

31 Aug 2022

State-level economic policy associated with reduction in HIV risk behavior among single mothers

UCLA research finds that a refundable State-level Earned Income Tax Credit (SEITC) of 10% or above the Federal EITC was associated with a 21% relative risk reduction in reported behavior that could put single mothers at high risk for becoming infected with HIV during the previous year.

30 Aug 2022

IBS discussed collaboration with NIAID and St. Jude’s Children’s Research Hospital

The Institute for Basic Science recently visited the National Institutes of Health and announced its collaboration with St. Jude Children's Research Hospital in the U.S., with the aims of increasing virus research capacity and ability to respond to infectious disease outbreaks.

29 Aug 2022

NIH experts discuss a published case series detailing the symptoms and outcomes of monkeypox

Lessons learned from the public health responses to the HIV and COVID-19 pandemics should help guide the response to the current outbreak of monkeypox, National Institutes of Health experts write in an editorial published today in the New England Journal of Medicine.

25 Aug 2022

Recent rise in STIs in the U.S. foreshadows the new monkeypox outbreak

The recent rise in sexually transmitted infections (STIs) in the United States foreshadowed the new monkeypox outbreak.

24 Aug 2022

A needle exchange project modeled on urban efforts aims to save lives in rural Nevada

Richard Cusolito believes he's saving lives by distributing clean syringes and needles to people who use drugs in this rural area of northeastern Nevada — but he knows some residents disagree.

24 Aug 2022

AIDS News and Research

UW Medicine researchers seek participants for Phase 3 clinical trial of a drug to treat monkeypox

Court ruling may spur competitive health plans to bring back copays for preventive services

SARS-CoV-2 RNA and antibody detection in infected mothers’ breast milk

What is the impact of COVID-19 vaccination on erectile function?

ACTG announces the initiation of trial evaluating the safety and efficacy of monkeypox treatment

Phase 3 clinical trial commences to evaluate antiviral for monkeypox

Potential HIV vaccine component leads to strong protection in primates

COVID-19’s long-term impact on orphanhood and caregiver loss

Booster vaccination maintains high efficacy against malaria in African children

Recent literature reports on the role of the gut microbiome on human health and its effect on diseases

Study indicates that HIV-infected and uninfected patients have similar monkeypox illness outcomes

Recent developments in the use of nanoparticles to deliver drugs to the brain via intranasal administration

‘It’s becoming too expensive to live’: Anxious older adults try to cope with limited budgets

Dolutegravir-based regimen more effective for treating pregnant people with HIV-1

The currently available evidence on viral-induced parkinsonism

State-level economic policy associated with reduction in HIV risk behavior among single mothers

IBS discussed collaboration with NIAID and St. Jude’s Children’s Research Hospital

NIH experts discuss a published case series detailing the symptoms and outcomes of monkeypox

Recent rise in STIs in the U.S. foreshadows the new monkeypox outbreak

A needle exchange project modeled on urban efforts aims to save lives in rural Nevada

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News